Also, the expression of fibrosis-associated proteins vimentin and α-SMA in renal tissues was significantly decreased after anti-ANGPTL3/IL22 treatment, suggesting that the fusion proteins could mitigate the progression of renal fibrosis by alleviating podocyte injury and inhibiting inflammatory responses. The gene discussed is IL22; the disease is renal fibrosis.